Globe Life vs Manulife Financial: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Globe Life Inc (GL)

Q3 202613 Jul – 16 Aug 2026

▲2▼1

Globe Life: Bigger Buybacks and Bermuda Boost, But Weak Sales and Margins Weigh

Raised 2026 guidance and bigger buyback Globe Life lifted its 2026 earnings outlook to $15.55–$15.95 a share and increased planned buybacks to $670–$700 million, helped by a larger term loan. Buying back more stock shrinks the share count, which lifts earnings per share and supports the stock price.
This is the core new positive event that directly raised profit and shareholder-return expectations for GL.
Shares fell 6.1% despite upbeat guidance Even after raising guidance and buybacks, Globe Life shares dropped 6.1%. The market focused on long-term fundamentals rather than the improved numbers, showing investors remain skeptical about whether the good results can last.
It shows the market's real reaction to the guidance news and the underlying concern weighing on GL's price.
Mixed Q2: earnings beat, but sales and margins soften Globe Life beat on earnings, but weaker sales trends and softer underwriting margins offset the win. The stock looks about 4.8% undervalued at roughly $181 versus a $190 fair value estimate, so the market is weighing solid profits against slowing underlying growth.
It captures the mixed fundamental picture that explains why GL's price has not simply risen on the earnings beat.
Buyback expanded to $2.5 billion plus dividend Globe Life enlarged its share repurchase authorization to $2.5 billion and declared a $0.33 quarterly dividend. Returning more cash to shareholders supports the stock, though questions remain about how much per-share earnings growth comes from buybacks versus actual policy sales.
It is the latest capital-return move that directly affects GL's share count, dividend income, and investor sentiment.

July 202613 Jul – 16 Aug 2026

▲2▼1

Globe Life: Bigger Buybacks and Bermuda Boost, But Weak Sales and Margins Weigh

Raised 2026 guidance and bigger buyback Globe Life lifted its 2026 earnings outlook to $15.55–$15.95 a share and increased planned buybacks to $670–$700 million, helped by a larger term loan. Buying back more stock shrinks the share count, which lifts earnings per share and supports the stock price.
This is the core new positive event that directly raised profit and shareholder-return expectations for GL.
Shares fell 6.1% despite upbeat guidance Even after raising guidance and buybacks, Globe Life shares dropped 6.1%. The market focused on long-term fundamentals rather than the improved numbers, showing investors remain skeptical about whether the good results can last.
It shows the market's real reaction to the guidance news and the underlying concern weighing on GL's price.
Mixed Q2: earnings beat, but sales and margins soften Globe Life beat on earnings, but weaker sales trends and softer underwriting margins offset the win. The stock looks about 4.8% undervalued at roughly $181 versus a $190 fair value estimate, so the market is weighing solid profits against slowing underlying growth.
It captures the mixed fundamental picture that explains why GL's price has not simply risen on the earnings beat.
Buyback expanded to $2.5 billion plus dividend Globe Life enlarged its share repurchase authorization to $2.5 billion and declared a $0.33 quarterly dividend. Returning more cash to shareholders supports the stock, though questions remain about how much per-share earnings growth comes from buybacks versus actual policy sales.
It is the latest capital-return move that directly affects GL's share count, dividend income, and investor sentiment.

Latest13 Jul – 16 Aug 2026

▲2▼1

Globe Life: Bigger Buybacks and Bermuda Boost, But Weak Sales and Margins Weigh

Raised 2026 guidance and bigger buyback Globe Life lifted its 2026 earnings outlook to $15.55–$15.95 a share and increased planned buybacks to $670–$700 million, helped by a larger term loan. Buying back more stock shrinks the share count, which lifts earnings per share and supports the stock price.
This is the core new positive event that directly raised profit and shareholder-return expectations for GL.
Shares fell 6.1% despite upbeat guidance Even after raising guidance and buybacks, Globe Life shares dropped 6.1%. The market focused on long-term fundamentals rather than the improved numbers, showing investors remain skeptical about whether the good results can last.
It shows the market's real reaction to the guidance news and the underlying concern weighing on GL's price.
Mixed Q2: earnings beat, but sales and margins soften Globe Life beat on earnings, but weaker sales trends and softer underwriting margins offset the win. The stock looks about 4.8% undervalued at roughly $181 versus a $190 fair value estimate, so the market is weighing solid profits against slowing underlying growth.
It captures the mixed fundamental picture that explains why GL's price has not simply risen on the earnings beat.
Buyback expanded to $2.5 billion plus dividend Globe Life enlarged its share repurchase authorization to $2.5 billion and declared a $0.33 quarterly dividend. Returning more cash to shareholders supports the stock, though questions remain about how much per-share earnings growth comes from buybacks versus actual policy sales.
It is the latest capital-return move that directly affects GL's share count, dividend income, and investor sentiment.

Manulife Financial Corp (MFC)

Q3 202622 Jul – 2 Oct 2026

▲4

Manulife's AI Push, LTC Risk Cut, and Q2 Beat Drive Upside

AI Partnership with Microsoft Targets $1B Value Manulife expanded its Microsoft partnership to deploy AI tools across 30,000+ employees, aiming for over $1 billion in value by 2027. This can lower costs and speed innovation, supporting higher profits and a better stock price over time.
This is a major new strategic initiative that directly addresses future earnings growth.
New Global AI Chief and Hong Kong Deputy CEO Appointed Manulife named a Global Chief AI Officer and a Hong Kong Deputy CEO, signaling a push to use AI across underwriting and operations. This leadership focus can improve efficiency and competitiveness, especially in Asia, supporting the stock.
Leadership changes show commitment to AI and key market growth, which can drive future performance.
Q2 Earnings Beat on Asia Growth and Strong Sales Manulife reported Q2 core earnings of 79 cents per share, beating estimates, with revenue up 5.4% and sales up 21%. Strong Asia growth and improved efficiency show the business is performing well, which typically lifts the stock.
Earnings beat is a direct positive for investor confidence and stock price.
Long-Term Care Reinsurance Deal Closed, Cutting Risk Manulife closed a $3.2 billion reinsurance deal with Munich Re, reducing its long-term care risk by 24% cumulatively. This lowers uncertainty and frees up capital, which can support the stock by making earnings more stable.
Reducing a major risk overhang is a positive for valuation and investor sentiment.

August 202622 Jul – 2 Oct 2026

▲4

Manulife's AI Push, LTC Risk Cut, and Q2 Beat Drive Upside

AI Partnership with Microsoft Targets $1B Value Manulife expanded its Microsoft partnership to deploy AI tools across 30,000+ employees, aiming for over $1 billion in value by 2027. This can lower costs and speed innovation, supporting higher profits and a better stock price over time.
This is a major new strategic initiative that directly addresses future earnings growth.
New Global AI Chief and Hong Kong Deputy CEO Appointed Manulife named a Global Chief AI Officer and a Hong Kong Deputy CEO, signaling a push to use AI across underwriting and operations. This leadership focus can improve efficiency and competitiveness, especially in Asia, supporting the stock.
Leadership changes show commitment to AI and key market growth, which can drive future performance.
Q2 Earnings Beat on Asia Growth and Strong Sales Manulife reported Q2 core earnings of 79 cents per share, beating estimates, with revenue up 5.4% and sales up 21%. Strong Asia growth and improved efficiency show the business is performing well, which typically lifts the stock.
Earnings beat is a direct positive for investor confidence and stock price.
Long-Term Care Reinsurance Deal Closed, Cutting Risk Manulife closed a $3.2 billion reinsurance deal with Munich Re, reducing its long-term care risk by 24% cumulatively. This lowers uncertainty and frees up capital, which can support the stock by making earnings more stable.
Reducing a major risk overhang is a positive for valuation and investor sentiment.

Latest22 Jul – 2 Oct 2026

▲4

Manulife's AI Push, LTC Risk Cut, and Q2 Beat Drive Upside

AI Partnership with Microsoft Targets $1B Value Manulife expanded its Microsoft partnership to deploy AI tools across 30,000+ employees, aiming for over $1 billion in value by 2027. This can lower costs and speed innovation, supporting higher profits and a better stock price over time.
This is a major new strategic initiative that directly addresses future earnings growth.
New Global AI Chief and Hong Kong Deputy CEO Appointed Manulife named a Global Chief AI Officer and a Hong Kong Deputy CEO, signaling a push to use AI across underwriting and operations. This leadership focus can improve efficiency and competitiveness, especially in Asia, supporting the stock.
Leadership changes show commitment to AI and key market growth, which can drive future performance.
Q2 Earnings Beat on Asia Growth and Strong Sales Manulife reported Q2 core earnings of 79 cents per share, beating estimates, with revenue up 5.4% and sales up 21%. Strong Asia growth and improved efficiency show the business is performing well, which typically lifts the stock.
Earnings beat is a direct positive for investor confidence and stock price.
Long-Term Care Reinsurance Deal Closed, Cutting Risk Manulife closed a $3.2 billion reinsurance deal with Munich Re, reducing its long-term care risk by 24% cumulatively. This lowers uncertainty and frees up capital, which can support the stock by making earnings more stable.
Reducing a major risk overhang is a positive for valuation and investor sentiment.